Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9086542 | 1.00 | PPARG (0.67) | PPARGPPARA | |
| SCHEMBL9394182 | 0.91 | PPARG (0.65) | PPARGPPARA | |
| SCHEMBL8056865 | 0.88 | PPARG (0.59) | PPARGPPARA | |
| SCHEMBL8056861 | 0.88 | PPARG (0.59) | PPARGPPARA | |
| SCHEMBL9389108 | 0.87 | PPARG (0.61) | PPARGPPARA | |
| SCHEMBL9389106 | 0.87 | PPARG (0.61) | PPARGPPARA | |
| SCHEMBL7904698 | 0.85 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL4744468 | 0.84 | PPARG (0.63) | PPARGPPARA | |
| SCHEMBL7826289 | 0.81 | PPARG (0.68) | PPARGPPARA | |
| SCHEMBL9085087 | 0.80 | PPARG (0.81) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5589492-A | Heterocyclic compounds and their use in the treatment of Type-II diabetes | SMITHKLINE BEECHAM PLC (GB) | 1996-12-31 | — | — | US | claimed |
| EP-0635007-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES | SMITHKLINE BEECHAM PLC (GB) | 1995-01-25 | — | — | EP | claimed |
| WO-1993021166-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES | SMITHKLINE BEECHAM PLC (GB) | 1993-10-28 | — | — | WO | claimed |
| US-5589492-A | Heterocyclic compounds and their use in the treatment of Type-II diabetes | SMITHKLINE BEECHAM PLC (GB) | 1996-12-31 | — | — | US | disclosed |
| EP-0635007-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES | SMITHKLINE BEECHAM PLC (GB) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993021166-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF TYPE II-DIABETES | SMITHKLINE BEECHAM PLC (GB) | 1993-10-28 | — | — | WO | disclosed |